Neuberger Berman Group LLC Dexcom Inc Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Dexcom Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,129,632 shares of DXCM stock, worth $134 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,129,632

Holding current value

$134 Million

% of portfolio

0.13%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $129 Million - $158 Million	1,129,632 New	1,129,632 $157 Million
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $76.9 Million - $126 Million	-1,018,788 Reduced 36.56%	1,767,850 $219 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $79.9 Million - $128 Million	928,903 Added 50.0%	2,786,638 $260 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $6.4 Million - $7.45 Million	56,874 Added 3.16%	1,857,735 $239 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $46.6 Million - $55 Million	447,693 Added 33.08%	1,800,861 $209 Million

Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $46.1 Million - $66.5 Million	-542,099 Reduced 28.6%	1,353,168 $153 Million
Q3 2022 Nov 15, 2022	BUY	$76.35 - $94.18 $14.9 Million - $18.4 Million	195,731 Added 11.52%	1,895,267 $155 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $92.7 Million - $181 Million	1,362,809 Added 404.72%	1,699,536 $128 Million
Q1 2022 May 23, 2022	BUY	$94.08 - $130.2 $14.7 Million - $20.3 Million	156,050 Added 86.37%	336,727 $172 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $13.9 Million - $19.2 Million	-147,716 Reduced 44.98%	180,677 $90.7 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $10.2 Million - $12.8 Million	78,400 Added 31.36%	328,393 $175 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $11.3 Million - $15.2 Million	-106,341 Reduced 29.84%	249,993 $135 Million
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $16.3 Million - $21.7 Million	-200,939 Reduced 36.06%	356,334 $151 Million
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $4.56 Million - $5.63 Million	-53,762 Reduced 8.8%	557,273 $200 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $23.7 Million - $31.8 Million	303,990 Added 99.01%	611,035 $226 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $1.2 Million - $1.42 Million	-12,591 Reduced 3.94%	307,045 $31.6 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $8.54 Million - $14.3 Million	-136,195 Reduced 29.88%	319,636 $129 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $16.3 Million - $25.8 Million	340,741 Added 296.06%	455,831 $30.7 Million
Q4 2019 Feb 12, 2020	SELL	$36.62 - $57.29 $137,178 - $214,608	-3,746 Reduced 3.15%	115,090 $25.2 Million
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $164,255 - $202,487	4,623 Added 4.05%	118,836 $17.7 Million
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $4,844 - $6,772	-174 Reduced 0.15%	114,213 $17.1 Million
Q1 2019 May 13, 2019	SELL	$28.07 - $38.18 $549,049 - $746,800	-19,560 Reduced 14.6%	114,387 $13.6 Million
Q4 2018 Feb 12, 2019	SELL	$26.99 - $37.37 $341,261 - $472,506	-12,644 Reduced 8.63%	133,947 $16 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $1,144 - $1,799	49 Added 0.03%	146,591 $21 Million
Q2 2018 Aug 13, 2018	SELL	$17.54 - $25.22 $8.61 Million - $12.4 Million	-490,874 Reduced 77.01%	146,542 $13.9 Million
Q1 2018 May 08, 2018	BUY	$13.06 - $18.54 $6.94 Million - $9.85 Million	531,513 Added 501.89%	637,416 $47.3 Million
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $3.11 Million - $4.3 Million	-279,518 Reduced 72.52%	105,903 $6.08 Million
Q3 2017 Nov 15, 2017	BUY	$11.36 - $18.98 $4.38 Million - $7.32 Million	385,421	385,421 $18.9 Million

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

352M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $45.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Dexcom Inc Transaction History